MDxHealth Says Well-Positioned to 'Return to Positive EBITDA' - MDxHealth (NASDAQ:MDXH)

MDxHealth reports Q2 sales growth, mixed earnings and reaffirmed 2026 revenue guidance as tissue test volumes rise.

Raccontata dabenzinga.com